Reproductive Health

Maternity Nursing & Family-Centered Care

• Primary Focus: Focuses on the physical, emotional, and spiritual well-being of both the mother and the fetus or infant.

• Scope of Practice: Provides individualized health care, guidance, and educational support tailored to the client and the family unit.

Female Reproductive System: External Genitalia (Vulva)

• Mons Pubis: Fatty pad overlying the pubic symphysis, covered with pubic hair, which functions to protect the pelvic bones during intercourse.

• Labia Majora: Longitudinal folds of tissue extending down from the mons pubis that protect underlying delicate structures.

• Labia Minora: Delicate inner folds of skin that lubricate vulvar skin and secrete bactericidal fluids to prevent infection.

• Clitoris: Small, highly sensitive erectile tissue organ located beneath the prepuce, serving as the primary center of female sexual arousal.

• Prepuce of Clitoris & Head of Clitoris: Hood-like fold of tissue over the clitoral glans.

• Vestibule: Almond-shaped area enclosed by the labia minora that contains the urethral meatus, vaginal introitus, and openings of the Skene's and Bartholin's glands.

• Urethral Meatus: External opening of the urethra through which urine is excreted.

• Skene's Glands (Paraurethral Glands): Glands located on either side of the urethral orifice that secrete mucus to lubricate the vaginal opening.

• Bartholin's Glands: Glands situated posterolaterally to the vaginal orifice that secrete lubricating mucus during arousal.

• Hymen: Elastic, thin membranous tissue partially encircling or covering the external vaginal opening (introitus).

• Fourchette: Fold of skin forming the posterior margin of the vulva.

• Perineal Body: Fibromuscular structure located between the anus and the vaginal introitus that stretches significantly during child delivery.

• Anus: External outlet of the rectum.

Female Reproductive System: Internal Genitalia

• Vagina: Muscular, membranous tube connecting the external genitalia to the uterine cervix, acting as the female organ of copulation, outflow canal for menses, and birth canal.

• Uterus Alignment: In a non-pregnant state, the uterus is typically tilted forward in an anterior (anteverted) orientation.

• Uterine Structure:

  • Fundus: Muscular, rounded upper portion of the uterus above the insertion of the fallopian tubes.

  • Corpus (Uterine Body): Central region of the uterus located between the fundus and the isthmus.

  • Cornua: Junctions where the fallopian tubes enter the uterine cavity.

  • Isthmus: Lower, narrowed portion of the uterine cavity just above the cervix.

  • Cervix: Lower cylindrical neck of the uterus projecting into the upper vagina, composed of the internal os (opening into uterine cavity) and external os (opening into vagina).

• Anatomical Layers of the Uterus:

  • Perimetrium: Outer serous membrane layer covering the uterus.

  • Myometrium: Smooth muscle middle layer responsible for muscular contractions during labor.

  • Endometrium: Mucosal inner lining that thickens during the menstrual cycle and serves as the usual site for implantation of the fertilized ovum.

• Fornices: Recessed spaces around the protruding cervix:

  • Anterior Fornix: Recess located anterior to the cervix.

  • Posterior Fornix: Deep recess located behind the cervix where ejaculated semen pools to facilitate sperm entry into the cervical canal.

• Pouch of Douglas (Rectouterine Pouch): Anatomical space located between the posterior wall of the uterus and the anterior surface of the rectum.

Uterine Ligaments & Clinical Correlations

• Broad Ligaments: Double fold of peritoneum that forms a sheath covering over the pelvic cavity, maintaining the uterus in a centrally placed position.

• Round Ligaments: Fibromuscular bands extending from the uterine cornua to the labia majora that pull the uterus down and forward, aiding in directing the fetal presenting part into the cervix during labor.

• Cardinal Ligaments: Chief uterine support structures extending from the upper cervix and lateral vaginal fornices to the lateral pelvic walls; suspend the uterus in the true pelvis and prevent uterine prolapse.

  • Clinical Correlation: Dysfunction or laxity of the cardinal ligaments (frequently associated with multiparity or delivering infants weighing greater than $9\,\text{lbs}$) leads to uterine prolapse and feelings of vaginal fullness.

• Uterosacral Ligaments: Connect the upper cervix to the sacrum, helping to hold the cervix in place.

• Ovarian & Suspensory (Infundibulopelvic) Ligaments: Ligaments anchoring the ovaries to the uterus and lateral pelvic wall, carrying the ovarian blood vessels.

Fallopian Tubes and Ovaries

• Fallopian Tube Architecture:

  • Intrauterine Part: Segment passing through the uterine muscular wall.

  • Isthmus: Narrowed medial segment connecting the tube to the uterus; serves as the target site for surgical tubal ligation and sterilization.

  • Ampulla: Curved, dilated intermediate portion of the fallopian tube; acts as the primary site for egg fertilization.

  • Infundibulum & Fimbriae: Distal funnel-like end surrounded by finger-like fimbriae projections that sweep over the ovary to retrieve released ova.

• Ovaries:

  • Structure: Composed of germinal epithelium, cortex, and tunica albuginea.

  • Primary Function: Contain female gametes (ova) and secrete reproductive hormones, functioning as the primary source of estrogen and progesterone prior to pregnancy.

  • Endocrine Transition: Once pregnancy is established, the placenta replaces the ovaries as the primary producer of progesterone to maintain uterine quiescence.

Bony Pelvis Anatomy & Obstetric Implications

• Pelvic Division: Divided into the upper "False" pelvis and lower "True" pelvis by the linea terminalis.

• False Pelvis: Upper shallow basin above the pelvic brim that supports the weight of the enlarged gravid uterus and directs the fetus into the true pelvis.

• True Pelvis: Inferior bony passage critical for childbirth; inadequate dimensions cause Cephalopelvic Disproportion (CPD), preventing vaginal delivery.

• Key Measurements and Landmarks:

  • Pelvic Inlet: Upper boundary of the true pelvis defined by the sacral promontory, linea terminalis, and pubic crest. Entrance diameter determines if engagement of the fetal head occurs.

  • Transverse Diameter: Maximum width of the inlet, measuring approximately $13.5\,\text{cm}$.

  • Obstetric Conjugate: Distance between the sacral promontory and the inner surface of the pubic symphysis, measuring approximately $10\,\text{cm}$.

  • Ischial Spines: Prominent lateral bony projections forming the narrowest diameter of the mid-pelvis (interspinous distance measuring approximately $10.5\,\text{cm}$); serve as the anatomical reference point for evaluating fetal station ($0\,\text{station}$).

  • Pelvic Outlet: Inferior limit bounded by the ischial tuberosities and pubic arch; inadequate outlet angles cause outlet dystocia or shoulder dystocia.

Mammary Gland Structure & Lactation

• Anatomical Components: Skin, adipose tissue, connective tissue stroma, pectoralis major muscle, intercostal muscles, ribs ($1\text{st}$ to $6\text{th}$ ribs).

• Glandular Structure:

  • Alveoli: Glandular milk-producing tissues.

  • Lactiferous Ducts & Ampulla: Ducts conveying milk to dilated sinuses (ampullae) behind the areola, discharging at nipple openings.

  • Areola & Nipple: Pigmented area surrounding the central erectile nipple.

  • Cooper's Ligaments (Suspensory Ligaments): Fibrous bands supporting breast tissue against chest muscle fascia.

• Surgical Note: A history of breast reduction surgery does not inherently preclude successful breastfeeding, depending on the preservation of milk ducts and nipple innervation.

Female Reproductive Hormones

• Estrogens: Responsible for primary and secondary female sex characteristics, including breast enlargement, hip widening, uterine growth, body hair proliferation, and regulation of sexual libido.

• Progesterone: Prepares and stabilizes the endometrial lining for embryo implantation, thickens cervical mucus to form a protective barrier, promotes mammary glandular proliferation, and maintains uterine quiescence during pregnancy.

• Prostaglandins: Essential fatty acid derivatives acting locally to constrict or relax vascular and uterine smooth muscle tissues.

• Follicle-Stimulating Hormone (FSH): Pituitary gonadotropin that stimulates ovarian primary follicles to grow and mature.

• Luteinizing Hormone (LH): Pituitary gonadotropin triggering a drop in estrogen, triggering ovulation, and transforming the ruptured follicle into the progesterone-secreting corpus luteum.

The Ovarian Cycle

• 1. Follicular Phase (Days 1–14):

  • FSH stimulation causes immature ovarian follicles to develop.

  • The oocyte grows within the maturing follicle while estrogen levels rise.

  • Ovulation (Day 14): A surge in LH triggers follicle rupture, releasing the mature ovum into the fimbriated end of the fallopian tube.

• 2. Luteal Phase (Days 15–28):

  • Ruptured follicle converts into the corpus luteum.

  • The ovum moves into the ampulla of the fallopian tube, remaining fertile for $12\text{--}24\,\text{hours}$.

  • If fertilized, the egg reaches the uterus in $72\text{--}96\,\text{hours}$, implants into the endometrium, and begins secreting human chorionic gonadotropin ($\text{hCG}$).

  • If unfertilized, the corpus luteum degenerates, causing hormone levels to fall.

The Menstrual (Uterine) Cycle

• 1. Menstrual Phase: Shedding of the functional layer of endometrial cells accompanied by blood loss (defines Day 1 of the cycle).

• 2. Proliferative Phase: Estrogen secretion induces rapid cellular proliferation and endometrial thickening. Cervical mucus becomes clear, thin, watery, elastic (spinnbarkeit), and stretchy to promote sperm passage.

• 3. Secretory Phase: Progesterone surge induces marked glandular swelling, vascular hypertrophy, and glycogen accumulation, converting the lining into a nutrient-rich bed for implantation.

• 4. Ischemic Phase: Occurs if implantation fails. Rapid decline of estrogen and progesterone leads to vascular constriction, ischemic necrosis of the functional layer, corpus luteum demise, and subsequent onset of menses.

• Fertility Window: Standard cycle spans $28\,\text{days}$. Peak female fertility occurs between Days $12\text{--}14$ (or Days $13\text{--}15$) surrounding ovulation.

Male Reproductive System

• Testes: Primary reproductive organs located inside the scrotum; produce sperm and secrete testosterone.

• Scrotum: Cutaneous sac supporting the testes; regulates testicular temperature necessary for viable spermatogenesis.

• Epididymis: Coiled duct network along the posterior testis acting as a reservoir for sperm maturation and storage.

• Vas Deferens & Ejaculatory Ducts: Muscular tubes conveying sperm from the epididymis up through the ampulla to the ejaculatory duct and urethra.

• Urethra: Common passageway for urine and semen through the prostatic, membranous, and penile sections.

• Penile Structure: Contains corpus cavernosum penis, corpus spongiosum, glans, and prepuce/foreskin.

• Accessory Glands & Seminal Fluid Components:

  • Seminal Vesicles & Prostate Gland: Contribute seminal fluid rich in glucose (energy), prostaglandins (smooth muscle motility), alkaline secretions (neutralizing acidic vaginal environments), and clotting factors.

  • Bulbourethral (Cowper's) Glands: Secrete alkaline fluid prior to ejaculation.

Spermatozoon Structure & Cell Division

• Sperm Head: Contains the cell nucleus holding genetic material and the cap-like acrosome containing digestive enzymes to penetrate the egg's zona pellucida.

• Middle Piece: Packed with dense mitochondria supplying metabolic energy ($\text{ATP}$) for motility.

• Tail (Flagellum): Long whip-like filament powering propulsion.

• Mitosis: Somatic cell division producing two genetically identical daughter cells containing the complete diploid set of chromosomes ($46$ chromosomes).

• Meiosis: Specialized germ cell division producing haploid gametes ($23$ chromosomes) with half the genetic material.

• Gametogenesis:

  • Oogenesis: Production of female ova within ovaries; all primitive ova are formed prenatally during fetal life.

  • Spermatogenesis: Continuous production of male spermatozoa occurring within testicular seminiferous tubules, commencing at puberty.

The Process of Fertilization

• Gametocyte Lifespan: Ova remain fertile for $12\text{--}24\,\text{hours}$ post-ovulation. Sperm remain viable inside female tracts for $48\text{--}72\,\text{hours}$, but retain peak fertilizing capacity for approximately $24\,\text{hours}$.

• Site of Fertilization: Takes place in the ampulla of the fallopian tube.

• Mechanism: A single sperm penetrates the ovum's outer layer, triggering a membrane block preventing polyspermy.

• Zygote Formation: Nuclear fusion restores the diploid chromosome number ($46$ chromosomes total: $23$ maternal + $23$ paternal).

  • Female Chromosomal Sex: $46,XX$

  • Male Chromosomal Sex: $46,XY$

Embryonic Membranes & Twin Gestation

• Amnion: Inner fetal membrane enclosing the amniotic cavity filled with fluid, continuously surrounding the fetus.

• Chorion: Outer thick membrane covered in chorionic villi that forms the fetal side of the placenta.

Comprehensive Twinning Classification Table

Amniotic Fluid Physiology & Pathophysiology

• Composition: Formed from maternal serum constituents, albumin, vernix, uric acid, fetal urine, and lung surfactants (lecithin and sphingomyelin).

• Physiological Functions: Cushions fetus against external trauma, prevents umbilical cord compression, regulates intra-amniotic temperature, enables musculoskeletal movements, promotes symmetrical growth, and facilitates fetal lung development.

• Surfactant Evaluation: Fetal lung maturity is established by measuring the Lecithin/Sphingomyelin ($\text{L/S}$) ratio via amniocentesis.

  • Maturity Threshold: An $\text{L/S ratio} \ge 2:1$ confirms pulmonary lung maturity.

• Urinary Transition: After $20\,\text{weeks}$ gestation, amniotic fluid consists predominantly of fetal urine.

• Pathophysiology:

  • Polyhydramnios (Hydramnios): Excessive amniotic fluid volume exceeding $2000\,\text{mL}$.

    • Etiology: Associated with maternal diabetes mellitus (fetal hyperglycemia inducing osmotic diuresis/polyuria), GI tract anomalies (esophageal atresia impairing fetal swallowing), or multiple gestations.

  • Oligohydramnios: Abnormally low fluid volume below $400\,\text{mL}$ or an Amniotic Fluid Index ($\text{AFI}$) less than $5$.

    • Etiology: Caused by fetal renal agenesis, urinary tract obstructions, placental insufficiency (hypertension), or premature rupture of membranes.

Umbilical Cord Structure

• Vessel Architecture: Contains 3 vessels total: 2 Arteries and 1 Vein ($\text{AVA}$).

  • 1 Umbilical Vein: Carries oxygen-rich, nutrient-dense blood from the placenta to the fetus.

  • 2 Umbilical Arteries: Carry oxygen-depleted blood and metabolic waste products from the fetus back to the placenta.

  • Single Umbilical Artery (SUA): Presence of only 1 artery and 1 vein warrants evaluation for congenital cardiovascular or renal anomalies.

• Wharton's Jelly: Specialized gelatinous connective tissue surrounding cord vessels to prevent twisting, compression, and kinking.

• Innervation: Lacks sensory or motor nerve fibers; severance at birth causes no pain to mother or infant.

Placental Structure & Functions

• Maternal vs. Fetal Surfaces:

  • Fetal Side ("Shiny Schultze"): Smooth, glistening surface covered by the amnion, showing branching blood vessels.

  • Maternal Side ("Dirty Duncan"): Dark red, rough, lobulated surface divided into cotyledons that attach directly to the decidua basalis.

• Key Placental Functions:

  • Immunologic Functions: Acts as a selective barrier protecting the homograft fetus from maternal immune rejection.

  • Excretion: Eliminates fetal metabolic wastes ($\text{urea}$, $\text{uric acid}$, $\text{creatinine}$) into maternal blood.

  • Respiration: Facilitates gas exchange, oxygenating fetal blood and removing carbon dioxide.

  • Nutritional Support: Synthesizes and transfers essential nutrients including glycogen, cholesterol, and fatty acids.

  • Endocrine Synthesis: Produces hormones essential to maintain pregnancy, including human chorionic gonadotropin ($\text{hCG}$), estrogen, progesterone, and human placental lactogen ($\text{hPL}$).

Fetal Circulation Shunts

• Ductus Venosus: Vascular shunt bypassing the fetal liver, carrying oxygenated blood from the umbilical vein directly into the inferior vena cava.

• Foramen Ovale: Anatomic intra-atrial opening shunting blood directly from the right atrium to the left atrium, bypassing non-functional fetal lungs.

• Ductus Arteriosus: Vascular conduit connecting the pulmonary artery directly to the descending aorta, bypassing the high-resistance fetal pulmonary vascular bed.

Timeline of Fetal Development Milestones

• Week 4: Heart begins to beat; primitive arm and leg buds appear; somites (precursor vertebrae) form; primary lung buds and optic/auditory vesicles begin forming.

• Week 6: Trunk straightens; trachea develops; nares present; liver begins hematopoiesis (producing blood cells); heart circulates blood; digit rays separate; embryonic tail begins receding.

• Week 12: Facial profile well developed; eyelids fused closed; tooth buds appear; external genitalia clearly differentiated; functional fetal kidneys secrete urine; spontaneous movement occurs; fetal heart tones ($\text{FHT}$) detectable via Doppler ultrasound.

• Week 20: Subcutaneous brown fat deposits form; protective vernix caseosa and fine lanugo hair cover body; nipples and fingernails present; mother perceives fetal movement (quickening); fetal heartbeat audible via fetoscope.

• Week 24: Stage of fetal viability reached; primitive alveoli forming in lungs; grasp and startle reflexes present; unique fingerprints and footprints established; eyes structurally complete.

• Week 28: Rapid brain growth; central nervous system assumes primitive regulatory control; eyelids open; testes begin descending into scrotum; pulmonary capillaries and alveoli capable of gas exchange.

• Week 36: Subcutaneous fat stores increase significantly; lanugo hair begins thinning and disappearing.

• Week 38: Full term gestational landmark achieved ($37\,0/7\,\text{weeks}$ and beyond); skin appears smooth and polished; vernix caseosa remains isolated exclusively to major skin creases and folds; head circumference exceeds chest circumference; newborn exhibits active rooting and crying behaviors.

Gynecological & Pathophysiological Disorders

• Fibrocystic Breast Changes: Nodular thickening of normal breast tissue resulting from estrogen-progesterone imbalances.

  • Symptoms: Cyclic bilateral breast pain, tenderness, and lump swelling intensifying immediately prior to menses.

  • Diagnosis: Mammography, breast MRI, or fine-needle aspiration (FNA).

  • Treatment: Dietary restriction of caffeine, reduced sodium intake, and oral contraceptives.

• Endometriosis: Ectopic growth of functioning endometrial tissue outside the uterine cavity.

  • Etiology: Unclear; theories include retrograde menstruation backflow, cellular metaplasia, or immune defects.

  • Symptoms: Severe pelvic pain, dysmenorrhea, dyspareunia, and secondary infertility.

  • Diagnosis: Confirmed via diagnostic laparoscopy visualization.

  • Treatment: Surgical excision/ablation of ectopic tissue, NSAIDs, and oral contraceptives.

• Polycystic Ovarian Syndrome (PCOS): Endocrine disorder characterized by enlarged ovaries containing multiple small subcapsular cysts.

  • Symptoms: Irregular menses or amenorrhea, hyperandrogenism (elevated testosterone), central obesity, insulin resistance, type 2 diabetes risk, chronic anovulatory infertility, severe acne, androgenic alopecia, hirsutism, voice deepening, and increased muscle mass.

  • Diagnosis: Health history, laboratory hormonal panels, and transvaginal ultrasound.

  • Treatment: Combined oral contraceptives, Glucophage (metformin) for insulin sensitivity, and Spironolactone (Aldactone) for anti-androgen effects.

• Toxic Shock Syndrome (TSS): Multisystem toxin-mediated illness occurring in menstruating females or postpartum clients.

  • Etiology: Exotoxin production by Staphylococcus aureus associated with prolonged high-absorbency tampon use.

  • Symptoms: High fever, diffuse macular erythroderma rash (resembling sunburn) on the trunk, vomiting, profuse watery diarrhea, severe hypotension, and mucosal inflammation.

  • Diagnosis: Elevated blood urea nitrogen ($\text{BUN}$), elevated $\text{AST}$, $\text{ALT}$, bilirubin, and severe thrombocytopenia (low platelets).

  • Treatment: Immediate hospitalization, intensive fluid resuscitation ($\text{IVF}$) to maintain blood pressure, and systemic parenteral antibiotics.

• Bacterial Vaginosis (BV): Alteration of protective vaginal microflora with loss of Lactobacillus species.

  • Etiology: Overgrowth of anaerobic bacteria triggered by douching, frequent intercourse, or multiple partners.

  • Symptoms: Profuse, thin, watery, homogenous greyish-white vaginal discharge exhibiting a strong "fishy" odor.

  • Diagnosis: Vaginal $\text{pH} > 4.5$, positive amine test ("whiff test"), and presence of clue cells on wet mount slide prep.

  • Treatment: Oral or intravaginal Flagyl (Metronidazole) or clindamycin vaginal cream.

• Vaginal Candidiasis (Yeast Infection): Fungal overgrowth caused by Candida albicans.

  • Etiology: Secondary to systemic antibiotic therapy, oral contraceptive use, immunosuppression, or uncontrolled diabetes mellitus.

  • Symptoms: Thick, white, curdy (cottage-cheese-like) vaginal discharge, intense vulvar pruritus, erythema, and dyspareunia.

  • Diagnosis: Microscopic identification of budding yeast spores and pseudohyphae on potassium hydroxide ($\text{KOH}$) preparation.

  • Treatment: Oral Diflucan (Fluconazole) or topical Nystatin antifungals.

• Pelvic Inflammatory Disease (PID): Ascending infectious inflammatory disorder of the upper female genital tract (uterus, fallopian tubes, ovaries).

  • Etiology: Multiple sexual partners, intrauterine device ($\text{IUD}$) insertion, or untreated Neisseria gonorrhoeae and Chlamydia trachomatis infections. Leads to tubal scarring, ectopic pregnancy risk, and permanent tubal factor infertility.

  • Symptoms: Bilateral lower abdominal sharp cramping, pelvic pain, high fever, chills, dyspareunia, and purulent cervical drainage.

  • Diagnosis: Cervical cultures, leukocytosis on $\text{CBC}$, and elevated $\text{VDRL}/\text{RPR}$ screening.

  • Treatment: Broad-spectrum multi-antibiotic parenteral combinations.

• Urinary Tract Infections (UTIs):

  • Lower UTI (Cystitis):

    • Etiology: Colonization of the bladder by Escherichia coli, Enterococcus, or Staphylococcus species.

    • Symptoms: Low-grade temperature, dysuria, urinary frequency, urgency, and hematuria.

    • Diagnosis & Treatment: Urinalysis, urine culture; treated with oral antibiotics.

  • Upper UTI (Pyelonephritis):

    • Etiology: Ascending renal infection following unresolved lower cystitis.

    • Symptoms: High spiking fever, rigors/chills, flank pain, costovertebral angle ($\text{CVA}$) tenderness, and nausea.

    • Diagnosis & Treatment: Urine/blood cultures, $\text{CBC}$; treated with intravenous fluids, parenteral antibiotics, and analgesics.

Sexually Transmitted Infections (STIs)

• Trichomoniasis: Non-viral STI caused by the flagellated protozoan Trichomonas vaginalis.

  • Symptoms: Diffuse yellow-green frothy discharge, vulvar inflammation, severe itching, and dysuria.

  • Diagnosis: Microscopic visualization of motile trichomonads on wet mount slide.

  • Treatment: Oral Flagyl (Metronidazole) for both patient and partner.

• Chlamydial Infection: Most common bacterial STI, caused by Chlamydia trachomatis.

  • Symptoms: Frequently asymptomatic; may present with thin purulent discharge, dysuria, and pelvic pain.

  • Diagnosis: Nucleic acid amplification testing ($\text{NAAT}$) or lab culture.

  • Treatment: Oral Azithromycin or Doxycycline.

• Gonorrhea: Bacterial STI caused by Neisseria gonorrhoeae; major contributor to PID and tubal infertility.

  • Symptoms: Profuse purulent greenish-yellow discharge, severe dysuria, and vulvar edema.

  • Diagnosis: Cervical/urethral lab culture or $\text{NAAT}$.

  • Treatment: Intramuscular Rocephin (Ceftriaxone) combined with oral Azithromycin.

  • Gonococcal Ophthalmia Neonatorum: Severe neonatal conjunctivitis resulting from exposure to infected maternal cervical secretions during birth from an untreated mother; causes infant blindness.

• Herpes Genitalis: Chronic viral infection caused by Herpes Simplex Virus Type 1 ($\text{HSV-1}$) or Type 2 ($\text{HSV-2}$).

  • Symptoms: Painful, single or clustered blister-like vesicles on the penile shaft, vulva, vagina, cervix, or perianal skin that rupture into shallow ulcers.

  • Diagnosis: Viral culture or $\text{PCR}$ assay of active lesion fluid.

  • Treatment: Incurable; oral Acyclovir antiretroviral therapy suppresses viral replication and maintains dormancy.

• Syphilis: Systemic chronic disease caused by the spirochete Treponema pallidum.

  • Symptoms: Primary stage presents with a firm, painless chancre sore at site of entry; progresses to secondary lesions (wart-like condylomata lata plaques), generalized fever, malaise, and lymphadenopathy.

• Human Papillomavirus (HPV): Viral STI linked directly to cervical, vulvar, and penile dysplasia and malignancies.

  • Symptoms: Exophytic genital warts (condylomata acuminata).

  • Diagnosis: Biopsy of suspicious lesions or Pap smear co-testing.

  • Treatment: Topical podofilox, cryotherapy, shave surgical excision, or bichloroacetic acid removal.

Infertility & Reproductive Options

• Primary Infertility Definition: Failure to achieve a successful pregnancy after $12\,\text{months}$ of regular, unprotected sexual intercourse.

• Secondary Infertility Definition: Inability to conceive or sustain a pregnancy following one or more previous successful pregnancies.

• Essential Female Fertility Components: Favorable non-hostile cervical mucus; patent fallopian tubes with normal peristaltic motility; functional ovaries producing healthy mature ova; absence of pelvic adhesions/obstructions; receptive secretory endometrium; balanced hypothalamic-pituitary-ovarian hormonal axis.

• Essential Male Fertility Components: Adequate total count, normal morphology, and forward motility of ejaculated sperm; unobstructed seminal duct system; normal alkaline genital tract secretions; ability to deposit ejaculate near the external cervical os.

• Strategies to Optimize Conception: Avoid douching or artificial chemical lubricants; lie supine for $20\text{--}30\,\text{minutes}$ following intercourse to retain semen; schedule coitus every other day during the fertile window; reduce psychosocial stress; maintain optimal systemic nutrition.

• Diagnostic Evaluation Workup:

  • Female Evaluation: Basal Body Temperature ($\text{BBT}$) graphing, cervical mucus evaluation, serum hormone assays ($\text{FSH}$, $\text{LH}$, $\text{progesterone}$), endometrial biopsy, and transvaginal ultrasonography.

  • Male Evaluation: Semen analysis assessing density, motility, and structural morphology; evaluation for ductal obstruction.

• Pharmacological Therapies: Clomid (clomiphene citrate) to induce ovulation, exogenously administered Progesterone, Gonadotropins ($\text{FSH}$, $\text{LH}$ injections), and Parlodel (bromocriptine) to suppress hyperprolactinemia.

• Assisted Reproductive Technologies (ART):

  • Therapeutic Insemination: Mechanical deposition of donor or partner sperm directly into the cervical canal or uterine cavity.

  • In Vitro Fertilization (IVF): Surgical retrieval of mature oocytes, laboratory fertilization with sperm in culture, and subsequent transcervical transfer of developing embryos into the uterus.

  • Gamete Intrafallopian Transfer (GIFT): Laparoscopic retrieval of unfertilized eggs combined with sperm and placed directly into the fallopian tube, allowing natural fertilization in vivo.

  • Zygote Intrafallopian Transfer (ZIFT): Oocytes are fertilized in vitro, incubated to the zygote stage, and laparoscopically transferred into the fallopian tube.

• Psychosocial Dynamics: Infertility induces profound relational distress, guilt, frustration, financial strain, identity loss, loss of control, social stigma, and ambiguity regarding status as a couple.

Cytogenetics & Genetics Fundamentals

• Genome Organization: Human genetic material is arranged on $46$ chromosomes arranged in $23$ pairs.

  • Autosomes: $22\,\text{pairs}$ ($44$ individual chromosomes) of non-sex chromosomes.

  • Sex Chromosomes: $1\,\text{pair}$ ($2$ individual chromosomes) determining biological sex ($XX$ or $XY$).

• Karyotype: Formatted pictorial display of an individual's chromosomes arranged by size and centromere location.

• Phenotype: The physical, functional, or observable expression of an underlying genetic genotype.

Chromosomal Disorders

• Down Syndrome (Trisomy 21): Autosomal numerical abnormality caused by non-disjunction, resulting in an extra chromosome 21.

  • Karyotype Notation: $47,XX,+21$ or $47,XY,+21$.

• Turner Syndrome (Sex Chromosome Monosomy): Affects females due to a missing sex chromosome.

  • Karyotype Notation: $45,X$ ($45$ total chromosomes).

  • Clinical Manifestations: Short stature, webbed/wide neck, primary ovarian failure, congenital cardiac defects, trunk abnormalities, and permanent infertility.

• Klinefelter Syndrome (Sex Chromosome Polysomy): Affects males due to an extra X chromosome.

  • Karyotype Notation: $47,XXY$ ($47$ total chromosomes).

  • Clinical Manifestations: Small testicles, subnormal testosterone synthesis, reduced muscle mass, sparse facial/body hair, gynecomastia (enlarged breast tissue), and severe oligospermia/azoospermia.

• Structural Abnormalities: Chromosomal translocations (e.g., balanced or unbalanced Robertsonian translocations involving chromosomes 14 and 21), partial deletions, or duplication additions.

Autosomal Inheritance Patterns

Autosomal Dominant Inheritance

• Mechanics: Gene expression requires only one copy of an altered dominant allele ($A$) passed from an affected parent.

• Genotypic Outcomes:

  • $AA$ (Homozygous Dominant): Expresses disease trait.

  • $Aa$ (Heterozygous): Expresses disease trait.

  • $aa$ (Homozygous Recessive): Unaffected normal phenotype.

• Key Rules: Affected individuals have an affected parent; offspring of an affected heterozygous parent have a $50\%$ ($1/2$) risk of inheriting the disorder.

• Carrier Status: Individuals cannot be unaffected asymptomatic carriers of an autosomal dominant trait (if they carry the allele $A$, they express the disease).

• Clinical Examples: Huntington's disease, Achondroplasia (Dwarfism), and Polydactyly.

• Worked Example (Polydactyly): If a mother is heterozygous ($Bb$) and the father is homozygous affected ($BB$):

  • Offspring outcomes: $50\%$ $BB$, $50\%$ $Bb$. Every child ($100\%$) inherits at least one dominant allele $B$ and will express polydactyly.

Autosomal Recessive Inheritance

• Mechanics: Expression requires two copies of the altered recessive allele ($a$), meaning both parents must contribute an altered gene.

• Genotypic Outcomes:

  • $AA$ (Homozygous Dominant): Unaffected non-carrier.

  • $Aa$ (Heterozygous): Healthy asymptomatic carrier (does not express trait).

  • $aa$ (Homozygous Recessive): Expresses disease trait.

• Offspring Probabilities (Carrier Mother $Aa$ x Carrier Father $Aa$):

  • $25\%$ ($1/4$) chance of an affected child ($aa$).

  • $50\%$ ($1/2$) chance of an asymptomatic carrier child ($Aa$).

  • $25\%$ ($1/4$) chance of an unaffected, non-carrier child ($AA$).

• Clinical Examples: Cystic Fibrosis, Sickle Cell Disease, Tay-Sachs Disease.

• Worked Example (Cystic Fibrosis): If both parents are confirmed carriers ($Bb$), there is a $25\%$ probability of producing an affected child ($bb$), a $50\%$ probability of a carrier child ($Bb$), and a $25\%$ probability of a healthy non-carrier child ($BB$).

Prenatal Diagnostic Testing & Clinical Nursing Roles

• Diagnostic Modalities:

  • Genetic Ultrasound: Non-invasive anatomical screening for structural biomarkers or malformations.

  • Genetic Amniocentesis: Transabdominal aspiration of amniotic fluid at $14\text{--}16\,\text{weeks}$ gestation to harvest shed fetal cells for karyotyping and biochemical analysis.

  • Chorionic Villus Sampling (CVS): Transcervical or transabdominal biopsy of chorionic tissue at $8\text{--}10\,\text{weeks}$ gestation for rapid early karyotyping.

  • Alpha-Fetoprotein (AFP): Maternal serum screening evaluating risks for open neural tube defects or chromosomal trisomies.

  • Non-Invasive Prenatal Testing (NIPT): Cell-free fetal DNA ($\text{cfDNA}$) isolation from maternal blood to screen for numerical aneuploidies.

• Nursing Responsibilities: Identify families at elevated risk for hereditary genetic anomalies; evaluate client understanding and information needs; act as an interprofessional liaison; deliver non-directive education and specialty genetics referrals; facilitate psychosocial coping; ensure seamless continuity of family care.